IDiyas

For the Inventor, By the Inventor

Yongin-si, South Korea

Sang Yeul Han

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:

goldMedal13 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
silverMedal1 out of 2,607 
 
Korea Advanced Institute of Science and Technology
 patents
where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11174309 - Anti-ANG2 antibody (2021-11-16),
2. 10934350 - Humanized or affinity-matured anti ang-2 antibody and uses thereof (2021-03-02),
3. 10246511 - Fusion polypeptide capable of binding simultaneously to VEGF-C and VEGF-D (2019-04-02),
4. 10047154 - Angiopoietin-2 specific antibodies and uses thereof (2018-08-14),
5. 9994632 - Humanized or affinity-matured anti Ang-2 antibody and uses thereof (2018-06-12),
6. 9902767 - Method of blocking vascular leakage using an anti-ANG2 antibody (2018-02-27),
7. 9828422 - Anti-Ang2 antibody (2017-11-28),
8. 9725513 - Fusion polypeptide inhibiting VEGF-C, VEGF-D and/or angiopoietin-2, and use thereof (2017-08-08),
9. 9580497 - Antibody specifically binding to ANG2 and use thereof (2017-02-28),
10. 9562093 - Antibodies or antigen-binding fragments thereof specifically binding to VEGF-C and use thereof (2017-02-07),
11. 9527910 - Ang-2 specific antibodies and uses thereof (2016-12-27),
12. 9505841 - Use of an anti-Ang2 antibody (2016-11-29),
13. 9193768 - Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof (2015-11-24),

Title: The Innovative Contributions of Sang Yeul Han

Introduction

Sang Yeul Han is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target angiogenesis-inducing factors. With a total of 13 patents to his name, Han's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents is the development of an anti-ANG2 antibody. This antibody specifically binds to the angiogenesis-inducing factor Angiopoietin-2 (Ang2) and forms a complex with the Tie2 receptor. This innovation is crucial for understanding and potentially treating conditions related to abnormal blood vessel formation. Another notable patent is for a humanized or affinity-matured anti-Ang2 antibody, which also targets Ang2 and its interactions with the Tie2 receptor. These advancements highlight Han's commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Sang Yeul Han has worked with leading organizations in the technology and research sectors. He has been associated with Samsung Electronics Co., Ltd., where he contributed to various projects that leverage cutting-edge technology. Additionally, his tenure at the Korea Advanced Institute of Science and Technology has further solidified his reputation as a leading inventor in his field.

Collaborations

Throughout his career, Han has collaborated with talented individuals such as Kyung Eun Kim and Hyo Seon Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sang Yeul Han's contributions to biotechnology through his patents and collaborations demonstrate his dedication to advancing medical science. His work continues to pave the way for new treatments and therapies that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…